In view of the steadily increasing number of chemical compounds
used in various products and applications, high-throughput toxicity
screening techniques can help meeting the needs of 21st century risk
assessment. Zebrafish (Danio rerio), especially its
early life stages, are increasingly used in such screening efforts.
In contrast, cell lines derived from this model organism have received
less attention so far. A conceivable reason is the limited knowledge
about their overall capacity to biotransform chemicals and the spectrum
of expressed biotransformation pathways. One important biotransformation
route is the mercapturic acid pathway, which protects organisms from
harmful electrophilic compounds. The fully functional pathway involves
a succession of several enzymatic reactions. To investigate the mercapturic
acid pathway performance in the zebrafish embryonic cell line, PAC2,
we analyzed the biotransformation products of the reactions comprising
this pathway in the cells exposed to a nontoxic concentration of the
reference substrate, 1-chloro-2,4-dinitrobenzene (CDNB). Additionally,
we used targeted proteomics to measure the expression of cytosolic
glutathione S-transferases (GSTs), the enzyme family catalyzing the
first reaction in this pathway. Our results reveal that the PAC2 cell
line expresses a fully functional mercapturic acid pathway. All but
one of the intermediate CDNB biotransformation products were identified.
The presence of the active mercapturic acid pathway in this cell line
was further supported by the expression of a large palette of GST
enzyme classes. Although the enzymes of the class alpha, one of the
dominant GST classes in the zebrafish embryo, were not detected, this
did not seem to affect the capacity of the PAC2 cells to biotransform
CDNB. Our data provide an important contribution toward using zebrafish
cell lines, specifically PAC2, for animal-free high- throughput screening
in toxicology and chemical hazard assessment.